Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
10/30/2013 | EP2654670A2 Skin sanitizer compositions comprising alcohol based emulsion |
10/30/2013 | EP2654638A1 Composition for transdermal administration of non-steroidal anti-inflammatory drug |
10/30/2013 | EP2654637A1 Kit-in-parts for cleaning and treating ears of companion animals |
10/30/2013 | EP2654461A2 Compositions and methods for improving mitochondrial function and treating neurodenegenerative diseases and cognitive disorders |
10/30/2013 | EP2654425A2 Ectoparasiticidal active substance combinations |
10/30/2013 | EP2654422A1 Bicyclo[3.2.1]octyl amide derivatives and uses of same |
10/30/2013 | EP2654421A1 Fused heterocyclic indane carboxamide cgrp receptor antagonists |
10/30/2013 | CN203252935U Anti-senile and life-prolonging plaster |
10/30/2013 | CN1989099B Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases |
10/30/2013 | CN103380214A Inhibitors of branched-chain-aminotransferase-1 (BCAT1) for the treatment of brain tumors |
10/30/2013 | CN103380142A Isoxazolidine derivatives |
10/30/2013 | CN103380141A Novel macrolide derivative |
10/30/2013 | CN103380140A 糖苷化合物 Glycoside compound |
10/30/2013 | CN103380134A N-[3-(5-amino-3,3a,7,7a-tetrahydro-1h-2,4-dioxa-6-aza-inden-7-yl)-phenyl]-amides as BACE1 and/or BACE2 inhibitors |
10/30/2013 | CN103380133A Compounds and their use as BACE inhibitors |
10/30/2013 | CN103380132A Phenanthridine macrocyclic hepatitis c serine protease inhibitors |
10/30/2013 | CN103380131A Heteroaryl compounds as 5-ht4 receptor ligands |
10/30/2013 | CN103380130A Novel pyrazole and imidazole derivatives useful as orexin antagonists |
10/30/2013 | CN103380129A 2-carboxamide-4-piperazinyl-benzofuran derivative |
10/30/2013 | CN103380122A Novel benzodioxole piperazine compounds |
10/30/2013 | CN103380119A Substituted aminobutyric derivatives as neprilysin inhibitors |
10/30/2013 | CN103380118A Tau成像探针 Tau imaging probe |
10/30/2013 | CN103380117A Picolinamide inhibitors of kinases |
10/30/2013 | CN103380115A Sulfur derivatives as chemokine receptor modulators |
10/30/2013 | CN103380112A Indole derivatives as modulators of S1P receptors |
10/30/2013 | CN103380108A Palladium-copper catalysts for the homogeneous selective oxidation of thiol groups |
10/30/2013 | CN103379917A Pharmaceutical compositions |
10/30/2013 | CN103379908A Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents |
10/30/2013 | CN103379907A Method for enhancing engraftment of haematopoetic stem cells |
10/30/2013 | CN103379906A Therapeutic agent for corneal sensory nerve damage containing semaphorin inhibitor as active ingredient |
10/30/2013 | CN103379905A Treatment of obesity using non-daily administration of 6-0-(4-dimethylaminoethoxy) cinnamoyl fumagillol |
10/30/2013 | CN103379904A Bromfenac aqueous liquid composition having preservative efficiency |
10/30/2013 | CN103379903A Process for preparing nanoparticles of two polyamino acids of opposite charge, one of the two of which is in charge surplus |
10/30/2013 | CN103379902A Implantable device for controlled release of low solubility drug |
10/30/2013 | CN103379901A Formulations comprising methylthioninium chloride |
10/30/2013 | CN103374079A Methylated fucus evanescens oligose or methylated sulfated fucus evanescens oligose or salt thereof as well as preparation method and application thereof |
10/30/2013 | CN103374042A Dynamic anti-cancer platinum compound with two different ligands at syn-position |
10/30/2013 | CN103374041A Lewis acid mediated synthesis of cyclic esters |
10/30/2013 | CN103374021A Zinc binding group containing pyridopyrimidin inhibitor for HDAC (Histone Deacetylase) and mTOR (Mammalian Target of Rapamycin) |
10/30/2013 | CN103374017A Trivalent chiral nitrogen compound and application thereof |
10/30/2013 | CN103374015A Camptothecin derivative and preparation method thereof as well as application of camptothecin derivative in preparation of medicine for treating tumours |
10/30/2013 | CN103374014A Salt of chelidonine derivative |
10/30/2013 | CN103374013A Salt of dihydrosanguinarine derivative |
10/30/2013 | CN103374012A Salt of sanguinarine derivative |
10/30/2013 | CN103374011A Salt of dihydro nitidine derivative |
10/30/2013 | CN103374010A Salt of methoxy dihydronitidine derivate |
10/30/2013 | CN103374009A Salt of nitidine derivative |
10/30/2013 | CN103374008A Salt of chelerythrine derivative |
10/30/2013 | CN103374007A Salt of dihydrochelerythrine derivative |
10/30/2013 | CN103374002A Phosphodiesterase-5 inhibitor |
10/30/2013 | CN103374001A Imidazo triazines mTOR (Mammalian Target of Rapamycin) inhibitor |
10/30/2013 | CN103374000A Pyrimido diazepine compound as well as pharmaceutical composition and application thereof |
10/30/2013 | CN103373999A Purine compound, intermediate, preparation method and application thereof |
10/30/2013 | CN103373997A Zinc binding group containing pyridonaphthyridine inhibitor for HDAC (Histone Deacetylase) and mTOR (Mammalian Target of Rapamycin) |
10/30/2013 | CN103373996A Bicyclic derivatives serving as CRTH2 receptor antagonist |
10/30/2013 | CN103373994A Therapeutic compounds |
10/30/2013 | CN103373992A 1, 3, 4-Oxadiazole and pyridine (pyrazine) ring-containing acylhydrazone derivatives, preparation method and applications |
10/30/2013 | CN103373988A 1, 2, 4-Triazole and pyrazine ring-containing acylhydrazone derivatives, preparation method and applications |
10/30/2013 | CN103373987A Pyrazine ring-containing triazole derivatives, preparation method and applications |
10/30/2013 | CN103373986A Crizotinib prodrug, as well as preparation and application thereof |
10/30/2013 | CN103373985A 杂环化合物及其用途 Heterocyclic compounds and their use |
10/30/2013 | CN103373984A Hydrindene amide compound crystal form, preparation method and usage thereof |
10/30/2013 | CN103373981A Application of oxygen heterocycle containing sulfanilamide derivative |
10/30/2013 | CN103373971A Urea compounds serving as protein kinase inhibitors |
10/30/2013 | CN103373969A Phenyl imidazole ring-substituted amide compounds as well as preparation method and application for same |
10/30/2013 | CN103373966A 4-anilino quinazoline amido derivatives as well as preparation methods and applications thereof |
10/30/2013 | CN103373961A Preparation of (1, 3-diphenyl-1hydrogen-4-pyrazolyl) methyl benzoic acid serial compounds and applications in treatment of melanoma |
10/30/2013 | CN103373959A Preparation method of cis-benzyl isoquinoline compound and application thereof |
10/30/2013 | CN103373957A Chelate with functions of protecting nerve cells |
10/30/2013 | CN103373952A New crystal forms of carvedilol sulfate |
10/30/2013 | CN103373938A 4-ethoxy-1,3-phenylenedimethylene amide compounds as well as preparation methods and applications thereof |
10/30/2013 | CN103373921A 4-((substituted phenyl) difluoromethyl) phenoxy carboxylic acid derivatives as well as preparation method and medical application for same |
10/30/2013 | CN103373907A Biphenol compound with anti-tumor activity and pharmaceutical use of compound |
10/30/2013 | CN103373906A 2,4'-biphenol compound with angiogenesis inhibiting effect and pharmaceutica use thereof |
10/30/2013 | CN103373905A Biphenyl polyphenol compound with acetyl choline and butyrylcholine esterase inhibiting effect and use of compound |
10/30/2013 | CN103372218A microRNA related to autoimmune disease and application thereof |
10/30/2013 | CN103372216A Solid medical composition containing celecoxib |
10/30/2013 | CN103372212A Quinazoline molecular targeted medicinal composition |
10/30/2013 | CN103372211A Antiviral compound preparation for fish |
10/30/2013 | CN103372210A Application of berberine combined chemotherapeutic medicament in antitumor therapy |
10/30/2013 | CN103372202A Lactoprotein/fatty acid-containing composition, and preparation method and application thereof |
10/30/2013 | CN103372201A Hard capsule formula and production method thereof |
10/30/2013 | CN103372182A Automatic vibration electromagnetic wave massage plaster and preparation method thereof |
10/30/2013 | CN103372179A Plaster preparation for relieving pain, activating blood, softening hard mass and removing blood stasis, and preparation method thereof |
10/30/2013 | CN103372178A Medicament and preparation method thereof |
10/30/2013 | CN103372173A Quick-effective analgesic anaesthetic paste |
10/30/2013 | CN103372169A Preparation for treating alcoholism and dispelling effects of alcohol |
10/30/2013 | CN103372165A Novel pure traditional Chinese medicine spray for treating eczema |
10/30/2013 | CN103372162A Plaster for treating femoral head necrosis |
10/30/2013 | CN103372136A Traditional Chinese medicine for treating favus of scalp and preparation method thereof |
10/30/2013 | CN103372131A Immersion liquid conducive to treatment of dermatophytosis, tinea pedis, foot odor and helosis |
10/30/2013 | CN103372123A Preparation method of traditional Chinese medicine for treating dermatophytosis |
10/30/2013 | CN103372117A Chinese medicinal composition for treating otitis and preparation method thereof |
10/30/2013 | CN103372109A Outer application drug for treating scabies |
10/30/2013 | CN103372105A Eye care solution |
10/30/2013 | CN103372104A Refreshing agent |
10/30/2013 | CN103372081A Preparation method of Chinese herba preparation snake gall-dried orange peel oral liquid |
10/30/2013 | CN103372074A Traditional Chinese medicine composition for treating ache and preparation method |
10/30/2013 | CN103372061A Traditional Chinese medicine ointment for treating leuconychia |
10/30/2013 | CN103372055A Extraction process of total polyphenol as hypoglycemic active ingredient in cinnamon, total polyphenol composition and application thereof |